Hosted on MSN31m
NICE green lights two blood cancer therapies for NHS useBMS’ Breyanzi and Amgen’s Blincyto will now be available to patients in England with certain types of blood cancer.
During a Case-Based Roundtable® event, Natalie Galanina, MD, discussed data from the ZUMA-7 and TRANSFORM trials in the first ...
4don MSN
Brain inflammation, while a crucial part of the body's immune response, takes on a detrimental role in Alzheimer's disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback